An increase in exhaled CO concentration in systemic inflammation/sepsis

Area of Science:

• Critical Care Medicine
• Biochemistry
• Medical Diagnostics

Background:

• Sepsis remains a significant cause of mortality and morbidity in intensive care units.
• Inflammation-induced oxidative stress in sepsis degrades heme proteins, increasing cellular damage.
• Heme-oxygenase-1 (HO-1) is key in heme breakdown, producing carbon monoxide (CO).

Purpose of the Study:

• To explore the potential of measuring exhaled CO as a biomarker for HO-1 activity.
• To assess if exhaled CO can reflect inflammation and oxidative stress levels in sepsis patients.
• To investigate the correlation between exhaled CO and patient morbidity/mortality.

Main Methods:

• Review of existing literature on sepsis, oxidative stress, HO-1, and CO measurement.
• Analysis of studies reporting exhaled CO concentrations in various clinical conditions including sepsis.
• Examination of the relationship between CO levels and patient outcomes.

Main Results:

• Increased exhaled CO concentrations are observed in critical illness, post-surgery, and sepsis.
• HO-1 activity, indicated by CO production, is linked to heme degradation and oxidative stress.
• Preliminary data suggest a potential relationship between exhaled CO levels and mortality.

Conclusions:

• Exhaled CO measurement is a promising, non-invasive technique to monitor HO-1 activity in vivo.
• This method may serve as a valuable tool for assessing inflammation and oxidative stress in systemic inflammation.
• Further research is warranted to confirm the predictive value of endogenous CO production for sepsis-related morbidity and mortality.